AcroMeta says ATCLS technology not yet commercialized, no revenue generated to date

Reuters2026/09/09 12:33

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Acrometa responded to SGX queries on its proposed investment tied to the ATCLS technology, which has not generated revenue.
Macro-ATCLS has not been incorporated; ATCLS is currently managed and commercialised by Macro HRD SG.
Macro holds sole, exclusive, perpetual global rights to ATCLS, subject to definitive contractual arrangements.
ATCLS remains in R&D; testing has occurred in multiple laboratories, including Nanyang Technological University.
The opportunity was introduced by consultant Raphael Tham; Macro CEO Yoo Kim is an acquaintance of substantial shareholder Levin Lee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acrometa Group Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: 82JB7KET2SGOHGPG) on September 09, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

AcroMeta says ATCLS technology not yet commercialized, no revenue generated to date

You may also like

Crypto prices